Background: The esebssiwaagoT Q method is applicable for the of study cell gene recombination events as the esebssiwaagoT Q is a measure of the intracellular pressure required to establish a horizontal reading frame for alignment of a gene and its intergene bases for maximal transcription and recombination enzyme activity. B-cell differentiation stages have recently been studied by gene esebssiwaagoT Q -based pressuromodulation mapping. In this study, the B-cell differentiation stage pressuromodulation map is utilized as a template to simulate B-cell immunoglobulin locus recombination events that take place in the pressuromodulated state in vivo. Methods: Chromosome 14 (−) strand location 105,566,277 and 106,879,844 germline genes were recombined after determination of gene esebssiwaagoT Q s with respect to the germline, and then recombined genes were recombined further after determination of gene esebssiwaagoT Q s with respect to rearranged configurations. For both alleles, first, IGHD_-_ to IGHJ_ was performed, and then IGHV_-_ to IGHD_-_-IGHJ_ was performed. For Allele 1 (IGHM), internal consensus recognition sequence (iCSR) and further CSR isotype switchings were performed; and for Allele 2 (IGHD), homologous recombination was performed and initial allelic exclusion determined.
Background
Gene transcription is a pressuromodulated process, pressurotopic [1] [2] [3] . B-cell maturation has recently been studied by gene esebssiwaagoT Q -based pressuromodulation mapping of B-cell differentiation stage markers [4] . The esebssiwaagoT Q -based pressuromodulation map of B-cell differentiation stage genes accurately simulates Bcell maturation in vivo and applies to both the classical B-cell maturation pathway (2-allele T-cell mediated pressuromodulation effect pathway) and the parallel alternative non-classical B-cell maturation pathway (1-allele Tcell independent antigen-mediated pressuromodulation effect pathway).
The classical 2-allele T-cell dependent B-cell maturation pathway involves three phases.
The first phase is the antigen presenting cell (APC)-more primed CD4R+ CD40LG T-cell-mediated CD40R Bcell cell membrane (CM) polarization effect or less primed T-cell-mediated polarization effect myeloid bone marrow phase until the Immature B-cell stage (CM IgM+), during which there is Allele 1 (IGHM) VDJ and internal consensus sequence recognition (iCSR) (CM IgM+) and after which there is Allele 2 (IGHD) VDJ.
The second phase is the CD4R+ CD40LG T-cellmediated CD40R B-cell polarization effect lymph node phase until either the Mature naïve B-cell (CM IgM+ IgD+ or IgM+ IgM+) or Evolved mature naïve B-cell (CM IgG_ + IgG_+) stage, during which there is Allele 2 (IGHD) post-V(D)J homologous recombination (HR) or initial allelic exclusion followed by delayed IgM iCSR and primary, secondary or further CSR isotype switching [5] .
And, the third phase is the T-cell independent B-cell CM receptor antigenic pressuromodulation effectmediated extra-nodal periphery/tissue nidus secretory antibody phase upon exposure to either positive pressuromodulator antigens or negative pressuromodulator antigens, during which there is transformation from B-cell to B-pre-plasma cell followed by B-plasma cell node exiting diapedesis as a secretory long-lived B-plasma cell/plasmablast [6, 7] .
The parallel alternate non-classical 1-allele T-cell independent B-cell maturation pathway involves two phases, the myeloid bone marrow phase during acute exposure to antigenic positve pressuromodulators, when the T-cell is out of intracellular pressure window for CD40LG expression, making the myeloid phase a T-cell independent process; and then the extra-nodal periphery/tissue nidus secretory anibody B-plasma cell phase, which is also a Tcell independent pressuromodulator antigen dependent process.
The non-classical pathway myeloid bone marrow phase involves B-cell CM toll-like receptor (TLR)-mediated endocytosis for example, which substitutes for the T-cell-mediated B-cell polarization pressuromodulation effect in oscillating B-cell intracellular pressure in the marrow [⊂ 0.26 esebssiwaagoT Q units (CD40) 0.36-0.41 esebssiwaagoT Q units (PRDM1-0. 41) 0.10-0.14 esebssiwaagoT Q units ⊃] [4] through the Mature naïve B-cell stage (CM IgM+ IgD-). Thus, during the marrow phase, there is Allele 1 (IGHM) VDJ, iCSR (CM IgM+) and Allele 2 (IGHD) VDJ, which results in a circulating Allele 1 IgM+ only Mature (naïve) B-cell [8] .
And, the non-classical pathway T-cell independent extra-marrow periphery/tissue nidus phase results in the IgM+ only (IgM+ IgD-) secretory B-plasma cell or in a further CSRing B-cell and a Ig_+ only (Ig_+ IgD-) secretory B-plasma cell, both short-lived B-plasma cells/ plasmablasts [6, 9] .
The general intervals of B-cell gene recombination events are shown on the recently developed B-cell differentiation stage pressuromodulation map [4] , as are general intervals of internal consensus sequence recognition (iCSR), homologous recombination and further CSR antibody isotype switchings. Thus, the B-cell differentiation stage pressuromodulation map serves as a template for predicting B-cell gene rearrangement events.
B-cell gene recombination events can be predicted for both B-cell differentiation pathways when the following points are considered:
(1)The discordant mechanisms of the recombination enzyme actions on DNA segments, (a) RAG1 and RAG2 recombinases facilitate the excision of intervening variability (V_-_), diversity (D_-_) and joining (J_) genes, where V(D)J recombination does not require an esebssiwaagoT Q match [4] because the mechanism is as such [10] , while (b) AICDA and APOBEC3A-G cytidine deaminases facilitate the excision of intervening heavy chain (IGH_) genes, where iCSR [10, 11] , CSR recombination [10, 12, 13] and B-cell homologous recombination [14] do require an esebssiwaagoT Q match [4] ; (2)B-cell gene recombination begins at greater intracellular pressure on Allele 1 (IGHM) and results in earlier assembly and presentation of IgM on the cell membrane (CM) as compared to Allele 2 (IGHD); (3)D_-_ to J_ gene rearrangement process of the VDJ [10, [15] [16] [17] is a limited step process for each allele and the number of steps depend on the grade of the positive antigen pressuromodulation effect; (4)non-functional D_-_ genes are not present in the VDJ [18] , as they serve only the purpose of being stepping stone recombination genes for 2-step D_-_ to J_, and include IGHD1-20 (nf ), IGHD4-11 (nf ) and IGHD5-18 (nf ) with the exception of IGHD7-27 (nf ), which does not participate; and (5)the percentage of V(D)J IGHJ_ genes [18] for Allele 1 (IGHM) 2-step D_-_ to J_ is 40% (IGHJ6) and Allele 1 (IGHM) 1-step D_-_ to J_ is 10% (IGHJ5), and for Allele 2 (IGHD) 2-step D_-_ to J_ is 32% (IGHJ4) and Allele 2 (IGHD) 1-step D_-_ to J_ is 8.5% (IGHJ3),~1.5% (IGHJ2) and 8.5% (IGHJ1).
In this study, B-cell gene recombination is studied by determining germline gene esebssiwaagoT Q s, and rearranging germline genes to simulate actual pressuromodulated in vivo gene recombination events including (1) IGHD_-_ to IGHJ_, (2) IGHV_-_ to IGHD_-_-IGHJ_, (3) internal consensus sequence recognition (iCSR) for Allele 1 (IGHM) and homologous recombination or initial allelic exclusion for Allele 2 (IGHD); and (4) further CSR isotype switchings for Allele 1 (IGHM) or for both alleles.
Methods

Data mining
Locations of germline Ig heavy chain locus genes between chromosome 14 (−) strand location 105,566,277 and 106,879,844 [19] , as well as locations of downstream and upstream genes were mined at GeneCards (https:// www.genecards.org/) genomic neighborhood GeneLoc genome locator database and at LNCipedia.org database (http://www.lncipedia.org/), pseudogenes included and enhancers excluded [2, 4] (Additional file 1: Table S1 ).
The 5′ -> 3′ direction episodic sub-episode sums split-integrated weighted average-averaged gene overexpression tropy quotient (esebssiwaagoT Q ) method and overall approach to gene rearrangement The downstream and upstream intergene base distances were tabulated, and then the final 5′-> 3′ esebssiwaagoT Q (fract) for each gene was calculated in upstream anisotropic, upstream mesotropic, downstream anisotropic and downstream mesotropic parts. First, the 3′-> 5′ and 5′-> 3′ direction paired point tropy quotients (prpT Q s; fract) were determined. Second, initial anisotropic and mesotropic subepisode blocks (SEB; ASEB, MSEB) were determined, which are constant per episode where the number of initial SEBs for establishing a gene category with 100% sensitivity and 100% specificity (100% accuracy) are 5 initial SEBs for an Episode 2 category gene, 7 initial SEBs for an Episode 3 category gene, 9 initial SEBs for an Episode 4 gene, 11 initial SEBs for an Episode 5 gene, 13 initial SEBs for an Episode 6 gene. Third, on the basis of the initial SEBs, the final anisotropic and mesotropic sub-episode blocks (SEB; ASEB, MSEB) were determined, which are variable. And fourth, the 5′-> 3′ direction esebssiwaagoT Q s to the final esebssiwaagoT Q were determined, where a gene with an anisotropic final esebssiwaagoT Q for < 0.25 is an infrapressuromodulated gene (Infra gene), and where a gene with a mesotropic final esebssiwaagoT Q ≥ 0.25 < 0.75 is a supra-pressuromodulated gene (Supra gene). The detailed esebssiwaagoT Q method is in references [2, 4] .
Germline genes were recombined after determination of gene esebssiwaagoT Q s with respect to the germline, and recombined genes were recombined further after determination of gene esebssiwaagoT Q s with respect to the rearranged configuration. For both alleles, first, IGHD_-_ to IGHJ_ recombination was performed, and then IGHV_-_ to IGHD_-_-IGHJ_ recombination was performed. For Allele 1 (IGHM), internal consensus sequence recognition (iCSR) and further CSR isotype switchings were performed; and for Allele 2 (IGHD), homologous recombination was performed and initial allelic exclusion determined.
Gene esebssiwaagoT Q -based simulation of 2-step and 1-step IGHD_-_ and IGHJ_ recombinations for allele 1 (IGHM) and allele 2 (IGHD)
For both alleles, 2-step (1, 2a, 2b) and 1-step D_-_↔ J_ recombination simulations were performed.
For the 2-step D_-_↔ J_ stimulation: first, the nonfunctional (nf) germline genes were determined (Step 1 of 2) and the IGHJ_ gene was determined ( Step 1 of 2) to yield the recombined gene, IGHD_-_ (nf)-IGHJ_; second, the esebssiwaagoT Q s for the remaining IGHD_-_ and IGHJ_ genes with respect to IGHD_-_ (nf)-IGHJ_ were determined; and third, these genes with respect to IGHD_-_ (nf)-IGHJ_, the remaining IGHD_-_ with respect to IGHD_-_ (nf)-IGHJ_ (Step 2a of 2) and IGHJ_ genes with respect to IGHD_-_ (nf)-IGHJ_ (Step 2a of 2) were recombined to yield the final step recombined gene, IGHD_-_ -IGHJ_ (Step 2b of 2), ready for IGHV_-_ ↔ IGHD_-_-IGHJ_.
For the 1-step D_-_↔ J_ stimulation, the germline IGHD_-_ and IGHJ_ genes were recombined to yield the final recombined gene, IGHD_-_ -IGHJ_ (Step 1of 1), ready for IGHV_-_ ↔ IGHD_-_-IGHJ_.
Gene esebssiwaagoT Q -based simulation of IGHV_-_ and IGHD_-_-IGHJ_ recombinations for allele 1 (IGHM) and allele 2 (IGHD)
The most common variable genes were sampled. These genes included IGHV1-3, IGHV3-23, IGHV4-28, IGHV3-48, IGHV4-59 and IGHV4-61 with the exception of IGHV5-51 [18] . The IGHV_-_ to IGHD_-_-IGHJ_ recombination events through further CSR isotype switching recombinations were performed for V1-3, V3-23, and V5-51.
Gene esebssiwaagoT Q -based simulation of internal consensus recognition sequence (iCSR) recombination for allele 1 (IGHM) For Allele 1 (IGHM) [11] , internal consensus sequence recognition (iCSR) recombination was performed between MIR4537, MIR4507/MIR4538 and MIR4539 with respect to IGHV_-_-IGHD_-_-(IGHJ5)-IGHJ6. The complete recombined V(D)J gene is VDJ6 irrespective of whether it is the 1-step recombined IGHV_-_ -D_-_-J5 gene or the 2-step recombined IGHV_-_ -D_-_-J5-J6 gene.
Gene esebssiwaagoT Q -based simulation of homologous recombination for allele 2 (IGHD) and determination of initial allelic exclusion For Allele 2 (IGHD) [14] , homologous recombination ( Gene esebssiwaagoT Q -based simulation of consensus recognition sequence (CSR) antibody isotype switchings for allele 1 (IGHM)
For Allele 1 (IGHM) isotype switching [12, 13] , consensus sequence recognition (CSR) recombination was performed if there was an esebssiwaagoT Q match between a downstream Ig heavy chain gene IGHG3, IGHG1, IGHA1, IGHG4/IGHG2, IGHE and IGHA2 with respect to VDJ6-IGHM (± 0.015 units) and VDJ6-IGHM (± 0.015 units). If there was an esebssiwaagoT Q match with a downstream gene for example with IGHG3, then the esebssiwaagoT Q s for each remaining downstream Ig heavy chain gene IGHG1, IGHA1, IGHG4/IGHG2, IGHE and IGHA2 with respect to VDJ6-IGHG3 were determined, after which further esebssiwaagoT Q matches were determined and remaining downstream gene recombinations simulated.
Results
Germline IGH_ genes IGHA2 is a 3 episode, 7 initial SEB and final SEB gene that begins with a mesotropic SEB. IGHA2 has one instance of non-contributory anisotropy. IGHA2 is a 3 M (7) NCA gene with a final esebssiwaagoT Q of 0.10 (0.099).
IGHE is a 3 episode, 7 initial SEB and final SEB gene that begins with an anisotropic SEB. IGHE is a 3 A (7) gene with a final esebssiwaagoT Q of 0.11 (0.111).
IGHG4/IGHG2 is a 2 episode, 5 initial SEB and final SEB gene that begins with a mesotropic SEB. IGHG4/ IGHG2 has one instance of non-contributory anisotropy. IGHG4/IGHG2 is a 2 M (5) NCA gene with a final esebssiwaagoT Q of 0.16 (0.163).
IGHA1 is a 3 episode, 7 initial SEB and final SEB gene that begins with a mesotropic SEB. IGHA1 is a 3 M (7) gene with a final esebssiwaagoT Q of 0.13 (0.131).
IGHG1 is a 3 episode, 7 initial SEB and final SEB gene that begins with an anisotropic SEB. IGHG1 is a 3 A (7) gene with a final esebssiwaagoT Q of 0.12 (0.120).
IGHG3 is a 2 episode, 5 initial SEB and final SEB gene that begins with a anisotropic SEB. IGHG3 is a 2 A (5) gene with a final esebssiwaagoT Q of 0.08 (0.075).
IGHD is a 3 episode, 7 initial SEB and final SEB gene that begins with a mesotropic SEB. IGHD is a 3 M (7) gene with a final esebssiwaagoT Q of 0.09 (0.092).
IGHM is a 3 episode, 7 initial SEB and final SEB gene that begins with anisotropic SEB. IGHM is a 3 A (7) gene with a final esebssiwaagoT Q of 0.09 (0.088).
MIR4539 is a 3 episode, 7 initial SEB and final SEB gene that begins with a mesotropic SEB. MIR4539 has one instance of non-contributory anisotropy. MIR4539 is a 3 M (7) NCA gene with a final esebssiwaagoT Q of 0.08 (0.076).
MIR4507/MIR4538 is a 3 episode, 7 initial SEB and final SEB gene that begins with an anisotropic SEB. MIR4507/MIR4538 has one instance of non-contributory anisotropy. MIR4507/MIR4538 is a 3 A (7) NCA gene with a final esebssiwaagoT Q of 0.08 (0.081).
MIR4537 is a 3 episode, 7 initial SEB and final SEB gene that begins with a mesotropic SEB. MIR4537 has one instance of non-contributory anisotropy. MIR4537 is a 3 M (7) NCA gene with a final esebssiwaagoT Q of 0.06 (0.064) ( Table 1, Additional file 2: Table S2 ).
Germline IGHJ_ genes IGHJ6 is a 3 episode, 7 initial SEB and final SEB gene that begins with an anisotropic SEB. IGHJ6 is a 3 A (7) gene with a final esebssiwaagoT Q of 0.10 (0.097).
IGHJ5 is a 3 episode, 7 initial SEB and final SEB gene that begins with an anisotropic SEB. IGHJ5 is a 3 A (7) gene with a final esebssiwaagoT Q of 0.24 (0.235).
IGHJ4 is a 3 episode, 7 initial SEB and final SEB gene that begins with a mesotropic SEB. IGHJ4 has one instance of non-contributory anisotropy. IGHJ4 is a 3 M (7) NCA gene with a final esebssiwaagoT Q of 0.11 (0.110).
IGHJ3 is a 3 episode, 7 initial SEB and final SEB gene that begins with a mesotropic SEB. IGHJ3 is a 3 M (7) gene with a final esebssiwaagoT Q of 0.11 (0.112).
IGHJ2 is a 3 episode, 7 initial SEB and final SEB gene that begins with a mesotropic SEB. IGHJ2 is a 3 M (7) gene with a final esebssiwaagoT Q of 0.11 (0.114).
IGHJ1 is a 3 episode, 7 initial SEB and final SEB gene that begins with a mesotropic SEB. IGHJ1 has one instance of non-contributory anisotropy. IGHJ1 is a 3 M (7) NCA gene with a final esebssiwaagoT Q of 0.12 (0.116) ( Table 2, Additional file 3: Table S3 ). IGHD3-16 is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. IGHD3-16 has one instance of non-contributory anisotropy. IGHD3-16 is a 3 M (7) NCA gene with a final esebssiwaagoT Q of 0.31 (0.308).
IGHD3-10 is a 3 episode, 7 initial and final SEB gene that begins with an anisotropic SEB. IGHD3-10 has one instance of anisotropy converted-to-mesotropy, and non-contributory reverse/stIsotropy. IGHD3-10 is a 3 A (7) ACM NCstI gene with a final esebssiwaagoT Q of 0.34 (0.342).
IGHD2-8 is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. IGHD2-8 has one instance of non-contributory reverse/ stIsotropy. IGHD2-8 is a 3 M (7) NCstI gene with a final esebssiwaagoT Q of 0.30. (0.295).
IGHD2-2 is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. IGHD2-2 has one instance of non-contributory reverse/ stIsotropy. IGHD2-2 is a 3 M (7) NCstI gene with a final esebssiwaagoT Q of 0.30 (0.301) ( Table 3 , Additional file 4: Table  S4 ; Table 4 ).
Germline non-functional IGHD4-11 (nf) gene and IGHD5-8 (nf) for allele 2 (IGHD) 2-step (1 of 2) recombination IGHD4-11(nf ) is a 3 episode, 7 initial SEB and final SEB gene that begins with an anisotropic SEB. IGHD4-11(nf ) has one instance of anisotropy converted-tomesotropy IGHD4-11(nf ) is a 3 A (7) Table 5 ).
Germline functional IGHD_-_ genes un-involved in the 1st step of 2-step allele 2 (IGHD) recombination IGHD3-9 is a 3 episode, 7 initial and 3 final SEB gene that begins with a mesotropic SEB. IGHD3-9 has one instance of anisotropy converted-to-mesotropy, one instance of non-contributory anisotropy, and one instance of non-contributory reverse/stIsotropy. IGHD3-9 is a 3 M [7 (− 4): 3] ACM NCA NCstI gene with a final esebssiwaagoT Q of 0.24 (0.239).
IGHD1-7 is a 3 episode, 7 initial and 5 final SEB gene that begins with an anisotropic SEB. IGHD1-7 has one instance of anisotropy converted-to-mesotropy, one instance of non-contributory anisotropy, and non-contributory reverse/stIsotropy. IGHD1-7 is a 3 A [7 (− 2): 5] ACM NCA NCstI gene with a final esebssiwaagoT Q of 0.28 (0.276). IGHD6-6 is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. IGHD6-6 has one instance of indirect stIsotropy for mesotropy. IGHD6-19 is a 3 M (7) stIMfM gene with a final esebssiwaagoT Q of 0.27 (0.275).
IGHD5-5 is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. IGHD5-5 has one instance of non-contributory reverse/stIsotropy. IGHD5-5 is a 3 M (7) NCstI gene with a final esebssiwaagoT Q of 0.23 (0.233).
IGHD4-4 is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. IGHD4-4 has two instances of non-contributory reverse/stIsotropy. IGHD4-4 is a 3 M (7) NCstI × 2 gene with a final esebssiwaagoT Q of 0.26 (0.258).
IGHD3-3 is a 3 episode, 7 initial and 9 final SEB gene that begins with a mesotropic SEB. IGHD3-3 has one instance of non-contributory anisotropy, and one instance of non-contributory reverse/stIsotropy. IGHD3-3 is a 3 M [7 (+ 2): 9] NCA NCstI gene with a final esebssiwaagoT Q of 0.24 (0.243).
IGHD1-1 is a 3 episode, 7 initial SEB and 7* final SEB gene that begins with a mesotropic SEB. IGHD1-1 has one instance of anisotropy converted-to-mesotropy preceding ending confirmation (anisotropic SEB no. 8), and three instances of non-contributory reverse/stIsotropy. Table S4; Table 5 ).
Germline non-functional IGHD_-_ gene
IGHD7-27
† is a 3 episode, 7 initial SEB and final SEB gene that begins with a mesotropic SEB. IGHD7-27 † is a 3 M (7) gene with a final esebssiwaagoT Q of. 0.17 (0.165) † (Table 3 , Additional file 4: Table S4 ).
Germline IGHJ5 gene for allele 1 (IGHM) 2-step (1 of 2) recombination [and for allele 1 (IGHM) 1-step recombination] IGHJ5 is a 3 A (7) gene with a final esebssiwaagoT Q of 0.24 (0.235) ( Table 2 , Additional file 3: Table S3 ; Table 4 ). Table S4; Table 4 ). IGHD2-2 with respect to IGHD1-20-IGHJ5 is a 3 episode, 7 initial and 3 final SEB gene that begins with a mesotropic SEB. IGHD2-2 with respect to IGHD1-20-IGHJ5 has one instance of non-contributory reverse/stIsotropy. IGHD3-9 is a 3 M (7) NCstI gene with a final esebssiwaagoT Q of 0.30 (0.296).
IGHD2-8 with respect to IGHD1-20-IGHJ5 is a 3 episode, 7 initial and 3 final SEB gene that begins with a mesotropic SEB. IGHD2-8 with respect to IGHD1-20-IGHJ5 has one instance of non-contributory anisotropy, and one instance of non-contributory reverse/stIsotropy. IGHD2-8 with respect to IGHD1-20-IGHJ5 is a 3 M (7) NCA NCstI gene with a final esebssiwaagoT Q of 0.24 (0.238) ( Table 4 , Additional file 5: Table S5 ). IGHD4-17-IGHJ6 is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. IGHD4-17-IGHJ6 has one instance of non-contributory Table S5 ).
IGHD_-_-IGHJ_
Germline IGHJ2 gene for allele 2 (IGHD) 2-step (1 of 2) [and for allele 2 (IGHD) 1-step recombination]
IGHJ2 is a 3 M (7) gene with a final esebssiwaagoT Q of 0.11 (0.114) ( Table 2, Additional file 3: Table S3 ; Table 5 ).
Germline non-functional IGHD_-_ (nf) genes for allele 2 (IGHD) 2-step (1 of 2) recombination IGHD4-11(nf ) is a 3 A (7) ACM gene with a final esebssiwaagoT Q of 0.29 (0.293).
IGHD5-18 (nf) is a 3 M [7 (− 3): 4] NCA stIMfA gene with a final esebssiwaagoT Q 0.25 (0.254) ( Table 3 , Additional file 4: Table S4; Table 5 ).
IGHJ4 gene with respect to IGHD4-11 (nf)-IGHJ2 and IGHJ4 gene with respect to IGHD5-18 (nf)-IGHJ2 for allele 2 (IGHD) 2-step (2a of 2) recombination IGHJ4 with respect to IGHD4-11-IGHJ2 is a 3 episode, 7 initial and 9 final SEB gene that begins with an mesotropic SEB. IGHJ4 with respect to IGHD4-11-IGHJ2 has one instance of anisotropy converted-to-mesotropy. IGHJ4 with respect to IGHD4-11-IGHJ2 is a 3 M [7(+ 2): 9] ACM with a final esebssiwaagoT Q 0. 19 (0.193) .
IGHJ4 with respect to IGHD5-18-IGHJ4 is a 3 episode, 7 initial SEB and final SEB gene that begins with a mesotropic SEB. IGHJ4 with respect to IGHD5-18-IGHJ4 is a 3 M (7) gene with a final esebssiwaagoT Q of 0.17 (0.165) ( Table 5 , Additional file 6: Table S6) .
IGHD_-_ genes with respect to IGHD_-_ (nf)-IGHJ2 for allele 2 (IGHD) 2-step (2a of 2) recombination IGHD1-7 with respect to IGHD4-11-IGHJ2 is a 3 episode, 7 initial and final SEB gene that begins with an anisotropic SEB. IGHD1-7 with respect to IGHD4-11-IGHJ2 has one instance of non-contributory reverse/stIsotropy. IGHD1-7 with respect to IGHD4-11-IGHJ2 is a 3 A (7) NCstI gene with a final esebssiwaagoT Q of 0.31 (0.311).
IGHD6-6 with respect to IGHD4-11-IGHJ2 is a 3 episode, 7 initial and 5 final SEB gene that begins with a mesotropic SEB. IGHD6-6 with respect to IGHD4-11-IGHJ2 has one instance of anisotropy converted-tomesotropy, one instance of non-contributory anisotropy, and one instance of non-contributory reverse/stIsotropy. IGHD6-6 with respect to IGHD4-11-IGHJ2 is a 3 M [7(− 2): 5] ACM NCA NCstI gene with a final esebssiwaagoT Q of 0.27 (0.266).
IGHD4-4 with respect to IGHD4-11-IGHJ2 is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. IGHD4-4 with respect to IGHD4-11-IGHJ2 has one instance of non-contributory reverse/stIsotropy. IGHD4-4 with respect to IGHD4-11-IGHJ2 is a 3 M (7) NCstI gene with a final esebssiwaagoT Q of 0.27 (0.268).
IGHD3-3 with respect to IGHD4-11-IGHJ2 is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. IGHD3-3 with respect to IGHD4-11-IGHJ2 has one instance of non-contributory reverse/stIsotropy. IGHD3-3 with respect to IGHD4-11-IGHJ2 is a 3 M (7) NCstI gene with a final esebssiwaagoT Q of 0.16 (0.156).
IGHD3-9 with respect to IGHD4-11-IGHJ2 is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. IGHD3-9 with respect to IGHD4-11-IGHJ2 has one instance of anisotropy converted-tomesotropy. IGHD3-9 with respect to IGHD4-11-IGHJ2 a 3 M (7) ACM gene with a final esebssiwaagoT Q of 0.33 (0.332).
IGHD5-5 with respect to IGHD5-18-IGHJ2 is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. IGHD5-5 with respect to IGHD5-18-IGHJ2 has one instance of anisotropy converted-tomesotropy, and one instance of non-contributory reverse/ stIsotropy. IGHD5-5 with respect to IGHD5-18-IGHJ2 is a 3 M (7) ACM NCstI gene with a final esebssiwaagoT Q of 0.31 (0.308).
IGHD1-1 with respect to IGHD5-18-IGHJ2 is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. IGHD1-1 with respect to IGHD5-18-IGHJ2 has one instance of non-contributory reverse/stIsotropy, and one instance of indirect stIsotropy for mesotropy. IGHD1-1 with respect to IGHD5-18-IGHJ2 is a 3 M (7) NCstI stIMfM gene IGHD4-4-IGHJ4 is a 3 episode, 7 initial and final SEB gene that begins with anisotropic SEB. IGHD4-4-IGHJ4 has one instance of anisotropy converted-to-mesotropy. IGHD4-4-IGHJ4 is a 3 A (7) ACM gene with a final esebssiwaagoT Q of 0.33 (0.332).
IGHD3-3-IGHJ4 is a 3 episode, 7 initial and 9 final SEB gene that begins with a mesotropic SEB. IGHD3-3-IGHJ4 has one instance of anisotropy converted-tomesotropy. IGHD3-3-IGHJ4 is a 3 M [7(+ 2): 9] ACM gene with a final esebssiwaagoT Q of 0.26 (0.258).
IGHD3-9-IGHJ4 is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. IGHD3-3-IGHJ4 is a 3 M (7) gene with a final esebssiwaagoT Q of 0.32 (0.324).
IGHD5-5-IGHJ4 is a 3 episode, 7 initial and 3 final SEB gene that begins with a mesotropic SEB. IGHD5-5-IGHJ4 has one instance of a non-contributory anisotropy, and one instance of indirect stIsotropy for anisotropy. IGHD5-5-IGHJ4 is a 3 M [7(− 4): 3] NCA stIMfA gene with a final esebssiwaagoT Q of 0.30 (0.297).
IGHD1-1-IGHJ4 is a 3 episode, 7 initial and 6 final SEB gene that begins with an anisotropic SEB. IGHD1-1-IGHJ4 has one instance of a non-contributory anisotropy. IGHD1-1-IGHJ4 is a 3 A [7(− 1): 6] NCA gene with a final esebssiwaagoT Q of 0.34 (0.340) ( Table 5 , Additional file 6: Table S6 ).
Germline IGHJ5 gene for allele 1 (IGHM) allele 1 (IGHM) 1-step recombination IGHJ5 is a 3 A (7) gene with a final esebssiwaagoT Q of 0.24 (0.235 (Table 2, Additional file 3: Table S3; Table 4 ).
Germline functional IGHD_-_ genes for allele 1 (IGHM) 1-step recombination IGHD2-15 is a 3 episode, 7 initial SEB and final SEB gene that begins with a mesotropic SEB. IGHD2-15 has one instance of non-contributory anisotropy. IGHD2-15 is a 3 M (7) NCA gene with a final esebssiwaagoT Q of 0.29 (0.294).
IGHD1-14 is a 3 episode, 7 initial and final SEB gene that begins with an anisotropic SEB. IGHD1-14 has two instances of anisotropy converted-to-mesotropy, and one instance of non-contributory anisotropy. IGHD1-14 is a 3 A (7) ACM × 2 NCA with a final esebssiwaagoT Q of 0.29 (0.292).
IGHD6-13 is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. IGHD6-13 has one instance of non-contributory anisotropy, and one instance of non-contributory reverse stIsotropy. IGHD6-13 is a 3 M (7) NCA NCstI gene with a final esebssiwaagoT Q of 0.29 (0.286) ( Table 3 , Additional file 4: Table S4 ; Table 4 ).
IGHD_-_-IGHJ5 genes for allele 1 (IGHM) V-to-DJ after 1-step recombination IGHD2-15-IGHJ5 is a 3 episode, 7 initial SEB and final SEB gene that begins with a mesotropic SEB. IGHD2-15-IGHJ5 is a 3 M (7) gene with a final esebssiwaagoT Q of 0.25 (0.251).
IGHD1-14-IGHJ5 is a 3 episode, 7 initial and 3 final SEB gene that begins with a mesotropic SEB. IGHD1-14-IGHJ5 has one instance of anisotropy convertedto-mesotropy, and one instance of non-contributory anisotropy. IGHD1-14-IGHJ5 is a 3 M (7) ACM NCA gene with a final esebssiwaagoT Q of 0.15 (0.149).
IGHD6-13-IGHJ5 is a 3 episode, 7 initial and 9 final SEB gene that begins with an anisotropic SEB. IGHD6-13-IGHJ5 has one instance of anisotropy converted-to-mesotropy, and one instance of noncontributory anisotropy. IGHD6-13-IGHJ5 is a 3 A [7(+ 2): 9] ACM NCA gene with a final esebssiwaagoT Q of 0.20 (0.205) ( Table 4 , Additional file 5: Table S5 ).
Germline functional IGHJ3, IGHJ2 and IGHJ1 genes for allele 2 (IGHD) 1-step recombination IGHJ3 is a 3 M (7) gene with a final esebssiwaagoT Q of 0.11 (0.112).
IGHJ2 is a 3 M (7) gene with a final esebssiwaagoT Q of 0.11 (0.114).
IGHJ1 is a 3 M (7) NCA gene with a final esebssiwaagoT Q of 0.12 (0.116) ( Table 2, Additional file 3: Table S3;  Table 5 ).
Germline functional IGHD_-_ genes for allele 2 (IGHD) 1-step recombination IGHD1-26 is a 3 episode, 7 initial and final SEB gene that begins with an anisotropic SEB. IGHD1-26 has two instances of non-contributory anisotropy. IGHD1-26 is a 3 A (7) NCA × 2gene with a final esebssiwaagoT Q of 0.22 (0.217). IGHD2-21 is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. IGHD2-21 has one instance of non-contributory anisotropy. IGHD2-21 is a 3 M (7) NCA with a final esebssiwaagoT Q of 0.20 (0.205).
IGHD5-12 is a 3 episode, 7 initial SEB and final SEB gene that begins with a mesotropic SEB. IGHJ3 IGHD5-12 is a 3 M (7) gene with a final esebssiwaagoT Q of 0.22 (0.218) ( Table 3 , Additional file 4: Table S4; Table 5 ). Table 5 , Additional file 6: Table S6 ).
IGHD_-_-IGHJ_
Germline IGHV_ genes IGHV1-3/IGHV4-4 § with respect to IGHJ_-IGHD_-_ is a 3 episode, 7 initial and variable final SEB gene that begins with either an anisotropic SEB or a mesotropic SEB. The final esebssiwaagoT Q is variable.
IGHV3-23 is a 3 episode, 7 initial SEB and final SEB gene that begins with an anisotropic SEB. IGHV3-23 is a 3 A (7) gene with a final esebssiwaagoT Q of 0.33 (0.332).
IGHV4-28 is a 3 episode, 7 initial and 5 final SEB gene that begins with a mesotropic SEB. IGHV4-28 has one instance of anisotropy converted-to-mesotropy, and one instance of indirect stIsotropy for mesotropy. IGHV3-48 is a 3 episode, 7 initial SEB and final SEB gene that begins with an anisotropic SEB. IGHV3-48 is a 3 A (7) gene with a final esebssiwaagoT Q of 0.27 (0.274).
IGHV5-51/IGHV3-53 is a 2 episode, 5 initial SEB and final SEB gene that begins with an anisotropic SEB. IGHV5-51/IGHV3-53 has one instance of noncontributory anisotropy. IGHV5-51/IGHV3-53 is a 2 A (5) NCA gene with a final esebssiwaagoT Q of 0.25 (0.245).
IGHV4-59 is a 3 episode, 7 initial SEB and final SEB gene that begins with a mesotropic SEB. IGHV4-59 is a 3 M (7) gene with a final esebssiwaagoT Q of. 0.34 (0.336).
IGHV4-61 is a 3 episode, 7 initial SEB and final SEB gene that begins with a mesotropic SEB. IGHV4-61 is a 3 M (7) gene with a final esebssiwaagoT Q of. 0.26 (0.258) ( Table 6 , Additional file 7: Table S7 ).
Ig heavy chain genes before iCSR and homologous recombination after IGHV1-3-IGHD_-_-IGHJ6 IGHV1-3-IGHD_-_-IGHJ6 is a 3 episode, 7 initial and 9* final SEB gene that begins with a mesotropic SEB. MIR4537 with respect to V1-3-D_-_-J6 is a 3 episode, 7 initial and final SEB gene that begins with an anisotropic SEB. MIR4537 with respect to V1-3-D_-_-J6 is a 3 A (7) gene with a final esebssiwaagoT Q 0.25 (0.251).
IGHV1-3-IGHD_-_-IGHJ6 has one instance of
MIR4507/MIR4538 with respect to V1-3-D_-_-J6 is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. MIR4507/MIR4538 with respect to V1-3-D_-_-J6 is a 3 M (7) gene with a final esebssiwaagoT Q of 0.26 (0.260).
MIR4539 with respect to V1-3-D_-_-J6 is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. MIR4539 with respect to V1-3-D_-_-J6 is a 3 M (7) gene with a final esebssiwaagoT Q of 0.27 (0.268).
IGHD with respect to V1-3-D_-_-J6 is a 3 episode, 7 initial and final SEB gene that begins with an anisotropic SEB. IGHD with respect to V1-3-D_-_-J6 is a 3 A (7) gene with a final esebssiwaagoT Q of 0.20 (0.198) ( Table 7 , Additional file 8: Table S8 ).
Ig heavy chain genes after iCSR, homologous recombination and further CSRs after IGHV1-3-IGHD_-_-IGHJ6
V1-3-D_-_-J6-IGHM is a 2 episode, 5 initial and final SEB gene that begins with a mesotropic SEB. V1-3-D_-_-J6-IGHM is a 2 M (5) gene with a final esebssiwaagoT Q of 0.27 (0.275).
V1-3-D_-_-IGHD is a 2 episode, 5 initial and final SEB gene that begins with a mesotropic SEB. V1-3-D_-_-IGHD is a 2 M (5) gene with a final esebssiwaagoT Q of 0.32 (0.320).
V1-3-D_-_-IGHG3 is a 2 episode, 5 initial and 4 final SEB gene that begins with a mesotropic SEB. Table 7 , Additional file 8: Table S8 ).
See Table 7 and Additional file 8: Table S8 for with respect to V1-3-D_-_-IGHM, with respect to V1-3-D_-_-IGHD, with respect to V1-3-D_-_-IGHG3, with respect to V1-3-D_-_-IGHG4, and with respect to V1-3-D_-_-IGHA2 genes.
Ig heavy chain genes before iCSR and initial allelic exclusion after IGHV3-23-IGHD_-_-IGHJ6
IGHV3-23-IGHD_-_-IGHJ6 is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. IGHV3-23-IGHD_-_-IGHJ6 is a 3 M (7) gene with a final esebssiwaagoT Q of 0.29 (0.285).
MIR4537 with respect to V3-23-D_-_-J6 is a 3 episode, 7 initial and final SEB gene that begins with an anisotropic SEB. MIR4537 with respect to V3-23-D_-_-J6 is a 3 A (7) gene with a final esebssiwaagoT Q of 0.27 (0.272).
MIR4507/MIR4538 with respect to V3-23-D_-_-J6 is a 3 episode, 7 initial and final SEB gene that begins with n/a n/a quaternary CSR not applicable (n/a) n/a
V1-3-D_-_ -J6-IGHA2
(n/a) n/a (2)
(7)
0.18 (0.185) n/a n/a a lnc-AL901608. Table S9 ).
Ig heavy chain genes after iCSR and further CSRs following IGHV3-23-IGHD_-_-IGHJ6
V3-23-D_-_-J6-IGHM is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. V3-23-D_-_-J6-IGHA1 is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. V3-23-D_-_-J6-IGHA1 has one instance of anisotropy converted-to-mesotropy. V3-23-D_-_-J6-IGHA1 is 3 M (7) ACM gene with a final esebssiwaagoT Q of 0.17 (0.171).
V3-23-D_-_-J6-IGHM is a 3 M (7) gene with a final
V3-23-D_-_-J6-IGHE is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. V3-23-D_-_-J6-IGHE is a 3 M (7)) gene with a final esebssiwaagoT Q of. 0.21 (0.205).
V3-23-D_-_-J6-IGHA2 is a 2 episode, 5 initial and 7 final SEB gene that begins with an anisotropic SEB. V3-23-D_-_-J6-IGHA2 s a 3 A (7) gene with a final esebssiwaagoT Q of 0.21 (0.208) ( Table 8 , Additional file 9: Table S9 ).
See Table 8 and Additional file 9: Table S9 for with respect to V3-23-D_-_-J6-IGHM, with respect to V3-23-D_-_-J6-IGHG1, with respect to V3-23-D_-_-J6-IGHA1, with respect to V3-23-D_-_-J6-IGHE, and with respect to V3-23-D_-_-J6-IGHA2 genes.
Ig heavy chain genes before iCSR and initial allelic exclusion after IGHV5-51-IGHD_-_-IGHJ6
IGHV5-51-IGHD_-_-IGHJ6 is a 2 episode, 5 initial and final SEB gene that begins with a mesotropic SEB. MIR4537 with respect to V5-51-D_-_-J6 is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. MIR4537 with respect to V5-51-D_-_-J6 is a 3 M (7) gene with a final esebssiwaagoT Q of 0.15 (0.152).
MIR4507/MIR4538 with respect to V5-51-D_-_-J6 is a 3 episode, 7 initial and final SEB gene that begins with an anisotropic SEB. MIR4507/MIR4538 with respect to V5-51-D_-_-J6 is a 3 A (7) gene with a final esebssiwaagoT Q of 0.15 (0.155).
MIR4539 with respect to V5-51-D_-_-J6 is a 3 episode, 7 initial and final SEB gene that begins with a mesotropic SEB. MIR4539 with respect to V5-51-D_-_-J6 is a 3 M (7) gene with a final esebssiwaagoT Q of 0.16 (0.159).
IGHD with respect to V5-51-D_-_-J6 is a 3 episode, 7 initial and 9 final SEB gene that begins with an anisotropic SEB. IGHD with respect to V5-51-D_-_-J6 has one instance of anisotropy converted-to-mesotropy. IGHD with respect to V3-51-D_-_-J6 is a 3 A [7(+ 2): 9] ACM gene with a final esebssiwaagoT Q of 0.17 (0.169) ( Table 9 , Additional file 10: Table S10 ). IGHE (1788) 7667 (3) 7 (−) n/a n/a quaternary CSR not applicable (n/a)
Ig heavy chain genes after iCSR and further
IGHA2 (1508) 1508 (3) 7 (−) n/a n/a quaternary CSR not applicable (n/a) n/a V3-23-D_-_ -J6-IGHE (n/a) n/a (3) Table 9 , Additional file 10: Table S10 ). See Table 9 and Additional file 10: Table S10 for with respect to V5-51-D_-_-J6-IGHM, with respect to V5-51-D_-_-J6-IGHG1, with respect to V5-51-D_-_-J6-IGHA1, with respect to V5-51-D_-_-J6-IGHG4, with respect to V5-51-D_-_-J6-IGHE, and with respect to V5-51-D_-_-J6-IGHA2 genes.
Discussion
The intracellular pressure required to establish a horizontal reading frame for recombination of joining and diversity genes in native germline arrangement is the basis for predictable gene rearrangement Variability-to-diversity-to-joining gene recombination is close to perfect when it completes in the pressuromodulated state in vivo [18] . As true allelic exclusion of the non-classical pathway in every case is due to failure of Allele 2 (IGHD) homologous recombination and not a failure of VDJ, Allele 1 (IGHM) accounts for 50% of VDJs while Allele 2 (IGHD) accounts for the other 50% of VDJs in vivo. The frequencies of diversity (D), joining (J) and variability (V) gene distribution is known, that of IGHJ6 is 40% (esebssiwaagoT Q : 0.097), that of IGHJ5 is 10% (esebssiwaagoT Q : 0.235), that of IGHJ4 is 32% (esebssiwaagoT Q : 0.110), that of IGHJ3 is~8.5% (esebssiwaagoT Q : 0.112), that of IGHJ2 is~1.5% (esebssiwaagoT Q : 0.114) and IGHJ1 accounts for~8.5% (esebssiwaagoT Q : 0.116).
Allele 1 (IGHM) gene recombination begins first, when B-cell intracellular pressure is in the suprapressuromodulated gene expression range [4] . Only IGHJ5 that expresses at an esebssiwaagoT Q of 0.235 units can be the 1 st step candidate gene for Allele 1, which only leaves 1 other step for Allele 1 J ↔ D recombination. Thus, IGHJ5 is a 1-step J_ gene and recipient of 10% of Allele 1 one-step D_-_ genes 10% of the time, while it is a 2-step stepping stone J_ gene for Allele 1 non-functional (nf ) gene IGHD1-20 (nf ) (esebssiwaagoT Q : 0.406) the rest of the time, making IGHJ6 the recipient gene for 40% of the D_-_ genes involved in the 2-step of Allele 1 two-step.
Allele 2 (IGHD) gene recombination follows that of Allele 1, when B-cell intracellular pressure is in the infra-pressuromodulated range, IGHJ1 through IGHJ4 all express in the 0.110 to 0.116 esebssiwaagoT Q units range; of these, the first J_ gene IGHJ1 and the third one IGHJ3 are each present at a frequency of~8.5% and are Allele 2 1-step J_ genes. IGHJ2 is present at a frequency of~1.5% and is also an Allele 2 1-step J_ gene. As IGHJ2 is present at the lowest frequency, this implies that it is the 2-step stepping stone J_ gene for Allele 2 non-functional genes IGHD4-11 (nf ) (esebssiwaagoT Q : 0.293) and IGHD5-18 (nf ) (esebssiwaagoT Q : 0.254) the rest of the time, making IGHJ2 the recipient of 32% of Allele 2 two-step D_-_ genes.
Germline functional diversity genes in their native configuration and destined to participate in 2-step Allele 1 (IGHM) recombination have esebssiwaagoT Q s in the 0.342 to 0.295 units range, which is approximately 40% of D_-_ genes, while those germline functional diversity genes that participate in 1-step Allele 1 recombination have esebssiwaagoT Q s in the 0.294 to 0.286 units range, which is the remaining 10% of D_-_ genes.
Germline functional diversity genes in their native configuration and destined to participate in 2-step Allele 2 (IGHD) recombination have esebssiwaagoT Q s in the 0.276 to 0.233 units range, which is approximately 32% of D _-_ genes, while those germline functional diversity genes that participate in 1-step Allele 2 recombination have esebssiwaagoT Q in the 0.218 to 0.172 units range, which is the remaining 18% of D_-_ genes.
Germline non-functional diversity gene IGHD7-27 that does not participate in D to J recombination has an esebssiwaagoT Q of 0.165. Therefore, the intracellular pressure required to establish a horizontal reading frame for efficient RAG1 and RAG2 recombinase activity [4] is the basis for predictable B-cell joining and diversity gene recombination in the pressuromodulated state in vivo, of which the gene esebssiwaagoT Q is the measure as it is a property of the gene. The 1-step Allele 1 recombination process involves a less primed CD4R+ CD40LG T-cell-mediated CD40R B-cell CM polarization pressuromodulation effect when an intracellular pressure of 0.36 units is achieved, which is sufficient for PRDM1 expression at 0.36 units and B-cell cyclic pressure oscillation, however Allele 1 two-step does not take place. Instead, 1-step Allele 1 recombination takes place as an intracellular pressure of 0.30 esebssiwaagoT Q units is achieved when IGHJ5 (esebssiwaagoT Q : 0.235) to IGHD2-1 (esebssiwaagoT Q : 0.296) recombination takes place (J5 ⟶ D2-1). The 2-step Allele 1 (IGHD) gene recombination process can also take place as it requires a maximum intracellular pressure of 0.293 esebssiwaagoT Q units to engage IGHD4-11 (nf) for recombination with IGHJ2 (esebssiwaagoT Q : 0.114) (D4-11(nf) ⟶ J2).
Therefore, when the Allele 1 (IGHM) recombination process is a 2-step process (Fig. 1) .
The step 2a of the process is downhill and begins after RAG2 engages IGHD3-10 with respect to D1-20 (nf )-J5, which is the upper limit D_-_ gene with respect to D1-20 (nf )-J5 with an esebssiwaagoT Q of 0.402 units. Then, cell pressure decreases back down into the PRDM1 maximum expression range at 0.36 units, and thereafter, at a sufficient enough rate through the CD40 expression cell pressure of 0.26 units into peri-nadir at 0.15 plus minus 0.05 units, which defines four fifths of one limb of 1 st fully refractory period. In the downhill limb of the fully refractory period, RAG1 engages IGHD4-17 with respect to D1-20 (nf )-J5 at 0.15 (0.150) units, which is lower limit for D_-_ genes with respect to D1-20 (nf )-J5. The step 2a stage completes after RAG1 association with IGHJ6 with respect to D1-20-J5 at 0.101 units of the period nadir, when the two free ends of DNA come together to result in IGHD_-_-IGHJ6 (step 2b) (Fig. 1) .
The IGHD_-_-IGHJ6 recombined gene esebssiwaagoT Q range is 0.13 (0.133) to 0.30 (0.297) units and the IGHV_-_ gene esebssiwaagoT Q range with respect to IGHD_-_-IGHJ6 is an unestablished lower limit to 0.41 (0.415) units. The VDJ step of the process completes between the 1 st fully refractory pre-nadir period and the uphill limb of 2 nd maximum polarization period. The lower limit of the IGHV_ gene esebssiwaagoT Q range is unestablished as more variability genes need to be sampled (Fig. 1) . Allele 1 recombination is a 2-step process when a more primed CD4R+ T-cell is involved and the greater magnitude of the B-cell polarization pressuromodulation effect. This implies that during a more robust pressuromodulation effect:
(1) there is deceleration during the 2-step Allele 1 step 1 downhill limb around an intracellular pressure of 0.25 esebssiwaagoT Q units because it is a function of PRDM1 expression that results in full expression of CD40 at 0.26 units, after which there is maximum B-cell polarization and acceleration in the opposite direction with an uphill increase in cell pressure back to 0.41 units, then down into the PRDM1 expression pressure of 0.36 units;
and (2) there is acceleration during the step 2a downhill limb through the CD40 expression intracellular pressure into the fully refractory period because it is a function of preceding maximum CD40 expression followed by PRDM1 expression in series that then results in nonexpression of CD40 at 0.26 units, after which there is maintained acceleration downhill into the peri-nadir due to the PRDM1 C-MYC gene antagonism effect. Step 1 of the Allele 2 one-step recombination process begins during the downhill limb of the 1 st refractory period in between 0.22 (0.218) and 0.17 (0.172) esebssiwaagoT Q units at which the IGHD_-_ genes are substrates for RAG.
Step 1 completes to the point of IGHD_-_-IGHJ1, −J2 or -J3 during peri-nadir before the uphill limb in between 0.12 (0.116) and 0.11 (0.112) units at which the 1-step IGHJ_ genes, IGHJ1 (~8.5%), IGHJ2 (~1.5%) or IGHJ3 (~8.5%) are substrates for the same (Fig. 2) .
The step 1 IGHD_-_-IGHJ1, −J2 or -J3 recombined gene esebssiwaagoT Q range is 0.11 (0.114) to 0.35 (0.347) units and the IGHV_-_ gene with respect to IGHD_-_-IGHJ12, −J and -J3 esebssiwaagoT Q range is an unestablished lower limit to 0.41 (0.415) units. The VDJ step of the Allele 2 one-step process completes during the uphill limb of the 1 st fully refractory period into the 2 nd maximum polarization period (Fig. 2) .
The Allele 2 recombination process is a 1-step process during the more primed CD4R+ T-cell-mediated polarization effect and follows Allele 2 two-step after CD40 non-expression as Allele 1 one-step begins during the downhill limb of the 1 st fully refractory period. Step 1 of the Allele 2 two-step recombination process begins during the second downhill limb at an intracellular pressure of 0.29 esebssiwaagoT Q units with RAG association with either IGHD4-11 (nf ) (esebssiwaagoT Q : 0.293) or IGHD5-18 (nf ) (esebssiwaagoT Q : 0.254) followed by IGHJ2 association at 0.114 units during the 1 st peri-nadir, which results in IGHD4-11 (nf )-IGHJ2 or in IGHD5-18 (nf )-IGHJ2 (Fig. 2) .
The step 2a of 2 of the process begins in the perinadir at 0.16 (0.156) esebssiwaagoT Q units and continues units into the uphill limb of the 2 nd threefourths maximum polarization period when intracellular pressure increases to 0.33 (0.332) units, which is the cell pressure range for IGHD_-_ genes with respect to D1-14 (nf )-J2 and D5-18 (nf )-J2. Then, IGHD_-_ with respect to D1-14 (nf )-J2 or D5-18 (nf )-J2, and IGHJ4 with respect to D1-14 (nf )-J2 or IGHJ4 with respect to D5-18 (nf )-J2 gene recombination follows in the 3 rd three-fourths full-refractory period when the B-cell pressure is in the 0.19 (0.193) to 0.17 (0.165) esebssiwaagoT Q units range, and ends in IGHD_-_-IGHJ4 when step 2b is complete. There is no IGHD_-_ to IGHJ4 gene recombination during the first 3/8 ths refractory period in between the 2 nd three-fourths maximum polarization period and the 3 rd three-fourths full-refractory period, when cell division takes place (Fig. 2) .
The 2-step Allele 2 VDJ step begins with the 3rd threefourths maximum polarization period in the IGHD_-_-IGHJ4 recombined gene intracellular pressure range between 0.26 (0.258) and 0.35 (0.350) esebssiwaagoT Q units, and completes in the IGHV_-_ gene with respect to IGHD_-_-IGHJ4 cell pressure range between an unestablished lower limit and the PRDM1 expression pressure of 0.36 units as the upper limit (Fig. 2) due to a less pressuromodulated B-cell.
Allele 2 recombination is a 2-step process when Allele 1 recombination is a 1-step process as a less primed CD4R+ T-cell is involved, which results in lesser grade pressuromodulation of the B-cell. This implies that during a less robust pressuromodulation effect: (1) there is ¾ ths of maximum polarization during the maximum polarization periods but sufficient enough for full PRDM1 expression at 0.36 esebssiwaagoT Q units, and (2) there is ¾ ths of full refractoriness during the fully refractory periods during which there is only transient CD40 expression comparable to nonexpression.
Allele 1 (IGHM) 1-step recombination step involves germline IGHD_-_ and IGHJ5 recombination that results in IGHD_-_-IGHJ5 (step1) and then IGHV_-_ and IGHD_-_-J5 recombination that results in V_-_-DJ6
The Allele 1 one-step recombination process begins during the downhill limb after the 1st three-fourths maximal polarization period in between 0.29 (0.294) and 0.29 (0.286) esebssiwaagoT Q units range when the genes destined for Allele 1 one-step are horizontal, and completes to the point of IGHD_-_-IGHJ5 at 0.24 (0.235) esebssiwaagoT Q units just as the 1 st refractory period begins at which the 1-step IGHJ_ gene, IGHJ5 expresses (Fig. 1) .
The step 1 IGHD_-_-IGHJ5 recombined gene B-cell pressure range is 0.15 (0.149) to 0.25 (0.251) and the IGHV_-_ gene with respect to IGHD_-_-IGHJ5 esebssiwaagoT Q range is the unestablished lower limit to 0.36 esebssiwaagoT Q units. The 1-step Allele 1 VDJ begins in the peri-nadir and completes during the 2 nd threefourths maximum polarization period (Fig. 1) .
The Allele 1 recombination process is a 1-step process during the less primed CD4R+ T-cell-mediated B-cell polarization effect. The Allele 1 one-step process can begin after the 1 st three-fourths maximal polarization period during the downhill limb as the intracellular pressure decreases at a slower rate compared to the Allele 2 two-step process into the three-fourths refractory CD40 expression period.
Variability gene esebssiwaagoT Q s can be constant or variable
The variability genes that were sampled from 5′ to 3′ include, IGHV4-61, IGHV4-59, IGHV5-51, IGHV3-48, IGHV4-28, IGHV3-23 and IGHV1-3. All of these except IGHV1-3 have constant esebssiwaagoT Q s with respect to germline IGHD_-_ genes.
The esebssiwaagoT Q for IGHV1-3 varies depending on the downstream location of IGHD_-_-IGHJ6 in Allele 1 two-step or IGHD_-_-IGHJ4, IGHJ5 and IGHJ6 in series in Allele 2 two-step for example since the split integration includes the intergene distances downstream of these genes with respect to IGHV1-3.
IGHV_-_ to IGHDJ_ recombination results in VDJ6 for both alleles
Variability gene to DJ_ gene recombination results in VDJ6 for both Allele 1 (IGHM) 1-step D_-_-J5 genes and for Allele 2 (IGHD) 1-step D_-_-J1, −J2, −J3 and 2-step D_-_-J4 genes.
After IGHV_-_ to IGHD_-_-IGHJ1 for example, the V_-_-D_-_-J1 becomes a V_-_-D_-_-J1-J6 gene as the VDJ promoters offer sufficient transcription factor-bound anchoring stability for RNA polymerase to be able to transcribe the entire V-to-J6 complex. The VDJ promoters however do not offer enough stability for transcription further downstream to immunoglobulin heavy chain M (IGHM), which requires internal consensus sequence recognition (iCSR) excision of intervening bases around the MIR genes for VDJ6-IGHM. Analogously, homologous recombination displacement removal of intervening bases results in VDJ6-IGHD, which transcribes in toto as one gene.
This observation forms the basis for determining the gene esebssiwaagoT Q with respect to the correct VDJ, which is VDJ6.
CD4R+ T-cells are positively pressuromodulated
Antigen presenting cells (APC) scavenge endocytic antigens and re-present endocytic antigen fragments to the T-cell receptor (TCR) [21, 22] and other T-cell receptors [22] . Therefore, APC-mediated positive pressuromodulator antigen presentation to CD4R+ T-cells results in endocytic positive pressuromodulation of the CD4R+ T-cell.
More primed CD4R+ T-cells are subject to higher grades of positive pressuromodulation that results in maximal CD40LG expression and CD40LG R+ T-cellmediated CD40R+ B-cell polarization effect that increases B-cell pressure to 0.41 esebssiwaagoT Q units (Allele 1 two-step/Allele 2 one-step), while less primed T-cells are subject to lower grades of positive pressuromodulation, which only increases B-cell pressure into the PRDM1 expression range of 0.36 units (Allele 2 twostep/Allele 1 one-step).
Antigen presenting cell-dependent T-cell-mediated Bcell polarization is the primary mode of increasing B-cell pressure in the classical maturation pathway, where vaccines serve the purpose of boosting the response [23] .
B-cells are subject to the effect of both positive and negative forms of antigen pressuromodulation
The effects of positive pressuromodulation out-weigh those of mixed or negative forms during B-cell maturation from the VDJ pro-B-cell stage to the consensus sequence recognition (CSR) isotype switching Evolved mature B-cell stage, as it is during oscillating positive pressuromodulation [4] .
In the classical pathway the dominant form of pressuromodulation is T-cell-mediated B-cell polarization via CD40R, while in the non-classical pathway the dominant form is positive pressuromodulator antigen-mediated Bcell pressuromodulation such as toll-like receptor (TLR) [24] -mediated endocytic via high isoelectric point basic peptides such as profilin II [25] during acute infection for example.
The B-cell to plasma cell transformation takes place in the presence of an antigen load. The majority of antigens such as virus capsid peptide and microbe cell wall or membrane fragments [26] are positive pressuromodulators of cell surface receptors [1] , which increase and maintain B-plasma cell pressure in the suprapressuromodulated range (≥ 0.25 esebssiwaagoT Q units) [2] . A minority of antigens such as phospholipases and proteases [27] are negative pressuromodulators of cell membranes [1] , which decrease and maintain B-plasma cell pressure in the infra-pressuromodulated range (< 0.25 esebssiwaagoT Q units) [2] .
IGHV1-3 antibody heavy chain recombination sequence after IGHV1-3-IGHD_-_-IGHJ6 is iCSR followed by further CSRs for allele 1 (IGHM) and homologous recombination for allele 2 (IGHD)
For Allele 1 (IGHM), there is internal CSR (iCSR) [11] between the switch sequence region intergene bases of MIR4507 with respect to V1-3DJ6 (esebssiwaagoT Q : 0.260) and the sequence intergene bases of MIR4539 with respect to V1-3DJ6 (esebssiwaagoT Q : 0.268), which is the closest esebssiwaagoT Q match between the candidate MIR_ genes of the IGHM switch region. The resultant recombined gene is V1-3-D_-_-J6-remaining MIR/ MIRs-IGHM with an esebssiwaagoT Q of 0.275 (Table 7) , and the cell a CM IgM+ Mature naïve B-cell.
For Allele 2 (IGHD), there is homologous recombination displacement replacement of 442 intergene bases downstream of IGHJ6 of V1-3-D_-_-IGHJ6 (esebssiwaagoT Q : 0.226) by 443 intergene bases upstream of IGHD with respect to V1-3-D_-_-IGHJ6 (esebssiwaagoT Q : 0.198) [14] due to an esebssiwaagoT Q match between the two genes, at minus 0.014 units for the former (IGHD) and plus 0.014 units for the latter (V1-2-DJ6), which meets the esebssiwaagoT Q match criterion of ±0.015 units with reference to the gene as it is the point of convergence. The resultant gene is V1-3D_-_-J6-IGHD with an esebssiwaagoT Q of 0.320 (Table 7) .
For Allele 1 (IGHM), the downstream genes for further CSR to V1-3DJ6-IGHM (esebssiwaagoT Q : 0.275) are IGHG3 (esebssiwaagoT Q : 0.271) and IGHA2 (esebssiwaagoT Q : 0.258), but not IGHG1, IGHA1, IGHG4/IGHG2 and IGHE. The esebssiwaagoT Q match for IGHG3 with respect to V1-3DJ-IGHM is plus minus 0.002 units and that for IGHA2 is plus minus 0.0085 units. The former will be a primary IGHG3 switch-to-IGHM switch region CSR resulting in V1-3DJ6-IGHG3 with an esebssiwaagoT Q of 0.306, and the latter will be a direct primary IGHA2 switch-to-IGHM switch region CSR resulting in V1-3DJ6-IGHA2 with an esebssiwaagoT Q of 0.258 (Table 7) .
After primary CSR, the CD4R+ T-cell polarized 1 (Table 7) . The further CSR for the CM IgG4+ 2 nd generation nodal cell will be a tertiary CSR to IGHA2 with respect to V1-3DJ6-IGHG4 (esebssiwaagoT Q of 0.226), where there is a match at plus minus 0.0055 units, which results in CM IgHA+ 3 rd generation nodal cell. After both direct primary CSR between IGHA2 and V1-3DJ6-IGHM and indirect tertiary CSR between IGHA2 and V1-3DJ6-IGHG4, the resultant gene is the same, V1-3DJ6-IGHA2 expressed at 0.185 units, one expressed by a 1 st generation cell and the other by a 3 rd generation cell.
IGHV3-23 antibody heavy chain recombination sequence after IGHV3-23-IGHD_-_-IGHJ_-J6 is iCSR followed by further CSRs for allele 1 (IGHM) and initial allelic exclusion for allele 2 (IGHD)
For Allele 1 (IGHM), there is internal CSR between the sequence intergene bases of MIR4537 with respect to V3-23DJ6 (esebssiwaagoT Q : 0.272) and the intergene bases of MIR4539 with respect to V3-23DJ6 (esebssiwaagoT Q : 0.277), which is the closest esebssiwaagoT Q match and results in V3-23-D_-_-J6-remaining MIR/MIRs-IGHM with an esebssiwaagoT Q of 0.277 (Table 8) . For Allele 2 (IGHD), homologous recombination does not take place between IGHD (esebssiwaagoT Q : 0.208) and V3-23-D_-_-J6 (esebssiwaagoT Q : 0.285) as there is no esebssiwaagoT Q match (Table 8) . Instead, delayed internal CSR will follow, which will result in Allele 2 V3-23-D_-_-J6-remaining MIR/MIRs-IGHM and in further CSRs analogous to Allele 1.
For both alleles, the primary CSR esebssiwaagoT Q match genes for V3-23DJ6-IGHM (esebssiwaagoT Q : 0.277) are IGHG1 (esebssiwaagoT Q : 0.271) and IGHA2 (esebssiwaagoT Q : 0.258), respectively. A primary direct IGHG1-to-IGHM CSR at plus minus 0.003 units results in V3-23DJ6-IGHG1 that expresses at an esebssiwaagoT Q of 0.256, and a primary direct IGHA2-to-IGHM CSR at plus minus 0.0095 units results in V3-23DJ6-IGHA2 that expresses at an esebssiwaagoT Q of 0.208 (Table 8) .
The CM IgG1+/IgG1+ 1 st generation Evolved mature naïve B-cell secondary CSRs with IGHA1 with respect to V3-23DJ6-IGHG1 with an esebssiwaagoT Q of 0.263 that is sufficiently horizontal at minus 0.0035 units in reference to V3-23DJ6-IGHG1, which is the only potential CSR for V3-23DJ6-IGHG1 with a downstream gene and results in V3-23DJ6-IGHA1 with an esebssiwaagoT Q of 0.171 (Table 8) . Table 8 ).
The higher generation-Evolved mature naïve cells in reference to V3-23DJ6-IGHM are more somatically mutated B-cells to the point of B-cell to B-plasma cell transformation as they are the product of multiple CSRs [28] , particularly when CSRing around the intracellular pressures at which the somatic hypermutation (SHM) cytidine deaminases (CDA) are maximally expressed and available [4] .
IGHV5-51 antibody heavy chain recombination sequence after IGHV5-51-IGHD_-_-IGHJ_-J6 is iCSR followed by further CSRs for allele 1 (IGHM) and initial allelic exclusion for allele 2 (IGHD)
